Remicade IV Infusion Therapy

What is Remicade?

Remicade (infliximab) is a biologic drug used to treat several moderate to severe autoimmune inflammatory conditions: 

• Crohn’s disease in patients aged 6 years and older 
• Ulcerative colitis in patients aged 6 years and older 
• Rheumatoid arthritis (RA) (in combination with methotrexate treatment) 
• Psoriatic arthritis (PsA) 
• Chronic severe plaque psoriasis in adults 
• Ankylosing spondylitis (AS) 

How does Remicade work?

Tumor necrosis factor (TNF)-alpha is a protein in the immune system that helps regulate immune cells and inflammation in the body. Patients with one of the above conditions have bodies that produce too much TNF-alpha, which can cause the immune system to mistakenly attack cells in the digestive tract, joints, spine, and skin. The resulting inflammation is an underlying cause of the conditions listed above. Remicade reduces inflammation and symptoms of the above conditions by blocking TNF-alpha in the body. 

How is Remicade administered?

Remicade is administered intravenously. The first 3 doses of Remicade infusions are administered once during week 0, 2, and 6, and then maintenance doses are administered once every 8 weeks thereafter. Each infusion takes about 2 hours. 

Click here to visit the pharmaceutical website for Remicade.

Remicade patient Assistance program

• Janssen CarePath - REMICADE Assistance Cost Support

This product may be used to treat other conditions not listed. If you are currently using or have a physician’s order to begin using this product for an unlisted condition and you have questions about whether or not we can offer you infusion services, please call our office or fill out a form and a member of our team will reach out to you as soon as possible.

If you’d like more information about the other treatment options we offer, please visit the IVIg infusions or biologic injections pages to learn more.